obsessive – compulsive disorder. Obsessive-compulsive disorder
Conditions
Interventions
Intervention 1: Group 2: In this group patients will receive placebo Neurofeedback 2 times per week for 10 weeks and they also will receive sertraline 20-40 mg per day for 16 weeks. Intervention 2:
Treatment - Drugs
Group 3: In this group patients will receive sertraline 10 mg per day for 16 weeks.
Group 1: In this group patients will receive Neurofeedback 2 times per week For 10 weeks and they also will receive sertraline 20-40 mg per day for 16 weeks
Group 2: In this group patients will receive placebo Neurofeedback 2 times per week for 10 weeks and they also will receive sertraline 20-40 mg per day for 16 weeks
Sponsors
Vice chancellor for research and Technology, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Diagnosis of obsessive-compulsive disorder based on the psychiatrist's interview According to DSM-5 criteria, Taking sertraline, Be at least 18 and up to 60 years, The ability to read and write, A minimum score of 16 on the Yale Brown Obsessive Compulsive Scale. Exclusion criteria: The people with acute and serious mental disorders such as bipolar disorder, schizophrenia, etc, People with other medical illnesses such as head injuries, Neurologic Diseases, drug allergies, A history of substance abuse, The types of dementia and cognitive disabilities.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of symptoms of OCD. Timepoint: before and after the intervention. Method of measurement: Y_BOCS and CGI Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognitive ability and executive function. Timepoint: before and after the intervention. Method of measurement: Wisconsin, Stroop and Pasat tests. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeid Yazdi-Ravandi
Hamadan Universiety of Medical Sciences
Outcome results
None listed